Posted in | News

Skanska Inks Construction Contract for Second Stage of Advanced Research Facility in Lund, Sweden

Skanska has signed a contract with ESS, European Spallation Source, to build the second stage of a state-of-the-art research facility in Lund, Sweden. The total contract is worth SEK 1.2 billion and the work will be performed by Skanska Sweden (75 percent) and Skanska UK (25 percent). This means that SEK 900 M is included in order bookings for Skanska Sweden for the second quarter of 2015, and the remainder will be booked by Skanska UK in the same quarter.

Last year, Skanska and ESS signed a cooperation agreement for the whole construction project and a design contract for the first stage.

The construction project is planned in several stages where separate agreements are concluded at the beginning of each stage.

Skanska Sweden is one of Sweden’s largest construction companies, with operations in building and civil-engineering construction. The business unit has approximately 11,000 employees and revenue in 2014 amounted to approximately SEK 30 billion. In Sweden, Skanska is also active in the development of residential construction and commercial premises.

Skanska AB may be required to disclose the information provided herein pursuant to the Securities Markets Act.

Skanska is one of the world’s leading project development and construction groups with expertise in construction, development of commercial and residential projects and public-private partnerships. Based on its global green experience, Skanska aims to be the clients' first choice for Green solutions. The Group currently has 60,000 employees in selected home markets in Europe and in the US. Skanska's sales in 2014 totaled SEK 145 billion.

This and previous releases can also be found at www.skanska.com

This information was brought to you by Cision http://news.cision.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.